Journal of Inflammation Research
Volume 14, 2021 - Issue
Original Research
Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33
Angela J Okragly1 Immunology Research, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
https://orcid.org/0000-0002-1041-8000View further author information
https://orcid.org/0000-0002-1041-8000View further author information, Katie Brannon Corwin2 BioTechnology Discovery Research, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0002-3082-9325View further author information
https://orcid.org/0000-0002-3082-9325View further author information, Marikka Elia3 BioTechnology Discovery Research Eli Lilly and Company, San Diego, CA, USAhttps://orcid.org/0000-0002-4224-0761View further author information
https://orcid.org/0000-0002-4224-0761View further author information, , , , Tatiyana Shiyanova2 BioTechnology Discovery Research, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0002-9320-2933View further author information
https://orcid.org/0000-0002-9320-2933View further author information, , , , , Julian Davies3 BioTechnology Discovery Research Eli Lilly and Company, San Diego, CA, USAhttps://orcid.org/0000-0002-1715-3463View further author information
https://orcid.org/0000-0002-1715-3463View further author information, & Robert J Benschop1 Immunology Research, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0001-6313-5218View further author information
https://orcid.org/0000-0001-6313-5218View further author information show all